非酒精性脂肪肝
医学
高尿酸血症
胰岛素抵抗
代谢综合征
脂肪肝
疾病
尿酸
生物信息学
内科学
肝病
重症监护医学
肥胖
生物
作者
Dan‐Qin Sun,Shengjie Wu,Wen‐Yue Liu,Qian-Di Lu,Gui‐Qi Zhu,Keqing Shi,Martin Braddock,Dan Song,Ming‐Hua Zheng
标识
DOI:10.1517/14728222.2016.1096930
摘要
There is an urgent need to develop novel, safe and effective therapies for the growing NAFLD epidemic. Reduction of SUA may be a promising potential treatment for patients with NAFLD. Clinical studies are required to determine the therapeutic effect of attenuation of hyperuricemia in humans with NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI